Class 11 MHC molecules (Ia) are transmembrane glycoproteins that function as cell recognition structures during the initiation of an antigen-specific immune response (1). T lymphocytes of the helper-inducer lineage (Th cells) express receptors that recognize foreign antigens in association with the la glycoproteins. The binding of this complex ligand to the TCR is required for the activation of Th cells, an essential step in the promotion of antibody and cell mediated immune responses. Although the sequences of many la alleles and TCR molecules are now known (2, 3), the molecular details of the interaction that occurs between Ia, foreign antigen and the T cell receptor remains an enigma .
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Class 11 MHC molecules (Ia) are transmembrane glycoproteins that function as cell recognition structures during the initiation of an antigen-specific immune response (1) . T lymphocytes of the helper-inducer lineage (Th cells) express receptors that recognize foreign antigens in association with the la glycoproteins. The binding of this complex ligand to the TCR is required for the activation of Th cells, an essential step in the promotion of antibody and cell mediated immune responses. Although the sequences of many la alleles and TCR molecules are now known (2, 3) , the molecular details of the interaction that occurs between Ia, foreign antigen and the T cell receptor remains an enigma .
The murine Ia molecules, designated A (A~As) and E (Ea E#), are transmembrane glycoproteins, each consisting of a 33-kD a chain noncovalently associated with a 29-kD 0 chain. Both the a and the 0 chains contain two extracellular domains, designated a, and a2, (J, and 02, respectively (4) . Sequence analysis of allelic a and ,Q chain genes revealed that most polymorphic residues are located in the NH2-terminal a, and ,#, domains (5) (6) (7) (8) . These polymorphic residues, which tend to be clustered in three or four regions of the primary structure of the NH2-terminal domains, are believed to be responsible for determining allele specific antibody binding sites and T cell recognition properties of the la molecules (9) (10) (11) .
Allospecific antisera and mAbs directed against the la glycoproteins have been important tools for the characterization of MHC alleles (HLA typing in the human), H-2 recombinant mouse strains, and the biochemical purification of la molecules (12) (13) (14) . Since these reagents specifically block the activation of T cells in antigen presentation assays, they have been used for evaluating la structure-function relationships (15) . Recently, there has been increasing interest in the use of anti-la mAbs in an attempt to modulate the immune system and as therapeutic reagents in certain autoimmune diseases . Thus, the identification of residues comprising the Ia antigenic determinants will contribute to the identification of the functionally important regions on the la molecule .
Several advances have been made toward identifying antibody binding sites on la antigens . The chain specificity of anti-la mAbs and the relationship of different antibody binding sites have been addressed in the analysis of in vitro immunoselected la bearing cell lines and L cells transfected with la genes (19) (20) (21) (22) (23) . Exon-shuffling experiments further mapped the binding sites of the various A' reactive antibodies to the (3,-domain of the A, polypeptide (9) . Recently, antibody binding sites within the a, and /3, domains were investigated through the use of cell lines expressing genes that contained a limited number of mutations introduced by site-directed mutagenesis (11, 24, 25) . These results, together with the sequence analysis of the in vivo, spontaneous mutant bm 12 (26) , suggested that the residues in the polymorphic region around position 66 in the (3, domain were involved in determining antibody binding sites on the Ia molecule .
We have undertaken a comprehensive analysis of the structural basis of antibody binding sites on the ,#, domain of the Aa and Ad polypeptides . We constructed variant Ap genes that encoded single or multiple residues of the A'o polypeptide at 14 polymorphic positions in the ,0, domain . The mutant 0 chain polypeptides were expressed in combination with either the Ad or A. polypeptides after transfection of genes into the B lymphoma cell line M12.C3 . Analysis of the transfected cell lines using a panel of Ap-and Ad-reactive mAbs has enabled us to identify the polymorphic residues that are involved in determining these antibody binding sites.
Materials and Methods
Oligonucleotides. The following oligonucleotides were used for mutagenesis : 5 CATT- The oligonucleotide intended to change position 87 and region A were purchased from SYN-TEK AB, Umea, Sweden, and used without further purification . All other oligonucleotides were synthesized with a DNA synthesizer (model 380A ; Applied Biosystems, Inc., Foster City, CA) using the phosphoramidite method and were purified by polyacrylamide gel electrophoresis .
Mutagenesis. The method for site-directed mutagenesis used in this study was described previously (27) . The second exon of the A' gene was cloned into M13 mpIOam (Pharmacia Fine Chemicals, Piscataway, NJ) after a partial digestion of Cos . 1 .1 (kindly provided by Dr . Lee Hood, California Institute of Technology, Pasadena, CA) with the endonuclease Xcy 1 . The M13 clone contained a 731-bp insert with two Sst II endonuclease restriction sites closely flanking the second exon . The heteroduplex was formed using 2 wg of SSDNA from this clone together with 0 .5 jug of double-stranded M13 mp l Owild (Amersham Corp ., Arlington Heights, IL) that was double digested with the endonucleases Eco RI and Sma I in the polylinker region . 2-30 nmol of each oligonucleotide were used to introduce mutations and up to four different oligonucleotides were annealed to the heteroduplex in a single reaction . Filters were lifted from plates containing foci of infected MK-30 su-bacteria (all the bacterial strains required for the experiments were generously provided by Dr . HansJoachim Fritz, Max-Planck Institute for Biochemistry, Martinsried, Federal Republic of Germany) and were hybridized with the mutagenic oligonucleotides . M13 clones showing preferential hybridization were expanded and their entire second exon of the AO gene was sequenced by the dideoxy chain termination method (28) .
Construction of Mutant A#' Genes. Replicative form of M13 clones containing the desired mutations was digested with endonuclease Sst 11 and ligated into an A' gene construct that lacked the Sst 11 fragment . The A'# gene was originally cloned from the Cos . 1 .1 into puc 18 as a 12-kb Hind III/Hpa I fragment . Recombinant bacterial colonies were screened by an oligonucleotide that covers the Sst II site 5' to the second exon. The uptake of only one Sst 11 second exon fragment was confirmed by a partial restriction map of the isolated plasmids with endonuclease Sma 1. Before transfection preferential hybridization of the mutant A# gene constructs with the mutagenic oligonucleotides was checked by Southern blot analysis. The As 1k gene was constructed by ligating the second exon of A" contained in pCA 12 (provided by Dr. Lee Hood, California Institute of Technology) into an Ak gene construct that had the second exon deleted by Sst 11 digestion.
DNA-mediated Gene Transfer of M12.C3 Cells. The M12.C3 cell line, which was given to us by Dr. Laurie Glimcher, Harvard University, Cambridge, MA, was grown in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% heatinactivated FCS, 100 U/ml penicillin, 100 wg/ml streptomycin, 2 MM L-glutamine, 0.1 mM 2-ME and buffered to pH 7 .3 with 10 mM Hepes. 5-10 x 106 cells were mixed with 40 jug of pRSVneo plasmid (29) that was linearized with the endonuclease Barn HI, 25 ug of mutant Ag gene plasmid, and 40 jAg of Aa gene plasmid (both linearized with the endonuclease Hind III) in 0.6 ml medium containing 140 mM NaCl, 25 mM Hepes, 0 .75 mM Na2HP04, pH 7.4 (the A. gene, a gift from Dr. Laurie Glimcher, was recloned into puc 18 as a Hind III fragment) . Electroporation (30, 31) was carried out at 480 V/cm using the PDS Model ZA 1000 (Prototype Design Services, Madison, WI). The treated cells were resuspended in 12 ml of the culture medium described above and distributed to 12 wells ofa 24-well Costar (Cambridge, MA) plate. After 16 hr, 1 ml selective medium (culture medium plus 600 Ag/ml G-418 (Gibco Laboratories) was added to each well. 2-3 wk later G-418 resistant cells were subcloned by limiting dilution . Subclones were screened using a cell ELISA (19) with mAbs reactive to A0 or A#. Positive subclones were expanded for further analysis.
Quantitative Immunofuorescence . The mAbs used are listed in Tables I and IV . The staining procedure has been described previously (19) . All antibodies were used in form of culture supernatants . FITC-protein A (Pharmacia Fine Chemicals) was the developing reagent for IgG mAbs, and FITC-goat anti-mouse IgM (Meloy Laboratories Inc., Springfield, VA) for IgM mAbs. Control antibodies of the appropriate isotype were used to quantitate nonspecific binding . Cytofluorometric analyses were measured on a logarithmic scale and peak channel values were subsequently converted to linear values for calculating comparative immunofluorescence values.
Results
The Aa and AR polypeptides differ from each other by single amino acids at 13 positions in the 01 domain . In addition, the Ad polypeptide contains three amino acids at positions 65, 66, and 67 (designated 65-67) compared with a single amino acid present in the A' polypeptide (Fig. 1 a) . Using site-directed mutagenesis, we separately introduced codons characteristic of the d allele into the A# gene sequence at each of the polymorphic positions (Fig. 1 b) . The DNA sequence of the second exon, which encodes residues 6-96 of the 01 domain was determined for each of the mutant genes. The mutant As genes were cotransfected with the wild-type Aa gene and a neomycin resistance gene into the B lymphoma line M 12.C3 . As described previously, this B lymphoma line does not express its endogeneous Ad molecule on the cell surface (32) . The lack of Ad expression results from the absence of AQ mRNA, although functional Ad mRNA is present. After transfection, neomycin (G-418)-resistant bulk cell populations were cloned by limiting dilution . Individual clones were tested by cytofluorometric analysis to obtain cell lines that expressed similar levels of the mutant A'o polypeptide with the Aa polypeptide on the cell surface. Since the Aa and A# polypeptides preferentially associate with each other transfected M12 .C3 cells expressing the Ak3 polypeptide and high levels of Ak polypeptide express relatively small amounts of the Aa As hybrid molecules . In contrast, cells transfected with
Properties of Af,--reactive mAbs
Chain specificity was determined previously (15, 19) . (Table I) was selected for this analysis. The diverse origin of the antibodies was intended to maximize the number of potentially different antibody binding sites that could be investigated . As shown in Table II, T12 T13 T14 T17   Cell   T28   lines   T40 T63 T65-67 T75 T78 T85 T86 T89   39B  - The TA3 cell line was used as a standard (see under Fig. 1 ) . * 39J recognizes the Aa polypeptide .
antibody 40F, whereas the substitution of the three amino acids proline, glutamic acid, and isoleucine for a single tyrosine at position 66 in the Ak ' polypeptide eliminated the binding of those antibodies that define the allospecificities Ia .1 . Ia .17, and Ia .18 (mAbs 39B, 39E, 40M, 10-2 .16, 11-3 .25, 4-2.1, 4-2 .3). These cytofluorometric analyses, which used saturating amounts of anti-Ia antibodies, were designed to evaluate relative expression levels of cell surface Ia molecules. Additional analyses will be needed to determine if alterations in antibody binding affinities have been introduced by these mutations in the ,Q1 domain . One of the mutant clones (T14) expresses lower levels of A' molecules on the cell surface than the TA3 cell line (Table II) of mutant A' # polypeptides of the primary sequence (Fig . 2a) . Based on this pattern, we divided the ,Q, domain into four regions of pronounced interallelic variability . The regions (Fig .  2 
a) encompass residues at position 9-17 (region --A -. ), 63-67 (region --B -. ), 75-78 (region --C ), and 85-89 (region D )
. Sequences encoding the amino acids of the Ap polypeptide in these four regions were introduced into the A'O gene by site-directed mutagenesis. Oligonucleotides corresponding to each of the four regions were used simultaneously in a single mutagenesis reaction and allowed the isolation of clones containing single as well as multiple mutations (Fig . 2 b) . Transfection of the wild-type Aa gene together with mutant Ak genes that encode region --A of the Ad polypeptide did not result in cell surface expression of la molecules containing the A', polypeptide as determined by quantitative immunofluorescence analysis with A.-reactive mAbs (data not shown) . Staining of the transfected cells with an Ad .-reactive mAb (K24-199) revealed that the mutant Ao polypeptides containing substitutions characteristic of the d allele in region --A --were expressed on the cell surface in association with the endogenous A« polypeptide of the M12 .C3 cell line (Table IV) . This finding is in agreement with previous reports that the Ad polypeptide does not associate with the A', polypeptide (36, 37) and that a region controlling a/,Q chain association maps to the NH 2-terminal half of the f3, domain (10, 38) .
Cell lines expressing the mutant Ak polypeptides with regional changes in combination with either the Aa polypeptide or, in the case of a substitution of region A, in combination with the Ad polypeptide, were stained with the antibodies reactive to A' (Table IV) . All cell lines expressing Ak genes that encode region B of the AO polypeptide did not react with any Arreactive antibodies . Also of particular interest is the finding that the cell line expressing the gene that encodes regions ACD of the Ad polypeptide retained binding of all Apreactive antibodies . Substitutions of amino acids of the A# polypeptide at positions 28 and 40 also do not influence binding of the Ak reactive mAbs (Table II) (Table VI) . Therefore, the epitope recognized by this antibody is either determined by variable residues of regions --B --and --C --or determined in a more complex fashion. A recent analysis (38) of L cells transfected with Aa genes and various combinations of half-exonshuffled A, 6 genes is consistent with these observations . Their results indicated that although the binding of the MKD6 antibody to these exon-shuffled la molecules was dependent upon the presence of d allele residues in the carboxyl half of the al domain, polymorphic residues in both the N142-terminal half of the 01 domain and in the Aa polypeptide influenced the binding affinity of the MKD6 antibody . Antibodies Y-219 and Y-270, which did not stain any of the cell lines expressing A' polypeptides with regional changes, did react with the cell line expressing the mutant A' polypeptide containing tyrosine characteristic of the As polypeptide at position 40 (Table VI) . Binding was stronger to the cell line expressing this mutant A' polypeptide in association with the Ad polypeptide (T400) than to the cell line expressing the mutant As polypeptide predominantly in association with the Aa polypeptide (T40) . This result suggests that the binding sites of the antibodies Y-219 and Y-270 may be influenced by polymorphic residues on both the a and 0 chain polypeptides . The reactivity pattern of (Fig . 3) . However, antibody Y-212 did not bind stronger to cells expressing M .63 A# polypeptide associated with the A. polypeptide than to cells expressing M.63 Aa polypeptide associated with the A. polypeptide (data not shown) . The observation that the antibody binding site recognized by mAb Y-212 is determined by the polymorphic residues at both positions 40 and 63 suggests that these two residues may be adjacent to each other in the three-dimensional conformation of the Ad molecule .
Discussion
The extensive allelic structural diversity of la polypeptides determines the unique components of allospecific antibody binding sites. Although allelic amino acid variation in the 0, domain, and presumably the a, domain determine T cell recognition as well as allospecific antibody binding (9, 10, 23), it has not been possible to determine the significance of particular residues or regions within the O, domain due to the high number of polymorphic residues encoded by the naturally existing alleles. We have begun to address this question by producing a panel of cell lines expressing mutant A' polypeptides that contain amino acid substitutions characteristic of the d allele at single or multiple positions within the (3, These results suggest that the binding sites of these A'-and As-reactive antibodies are determined by the polymorphic amino acids at positions 40, 63, and 65-67.
Results from previous studies have indicated that certain amino acid substitutions in the polymorphic region around positions 63 and 65-67 result in the loss of antibody binding sites on the A, 3 chain. Substitution of three amino acids at positions 67, 70, and 71 in the A, polypeptide resulted in the loss of multiple allospecificities in the mutant mouse strain bm12 (26, 41) . Similarly, five immunoselected mutant Ia-bearing cell lines exhibiting defects in many of the A,k e antibody binding sites, contained single base substitutions in their As genes which led to amino acid changes at positions 59, 64, or 70 (21, 42) . Analysis of three cell lines transfected with mutant As genes encoding Ak 'O characteristic residues at positions 9, 13, or 65-67 revealed that only the change at position 65-67 resulted in loss of antibody binding sites characteristic of the Ab polypeptide (24) . These studies were limited, however, because only the loss of antibody binding was observed and only the effects resulting from alteration of a small portion of the ,0, domain was evaluated.
There remains the possibility that the antibody binding sites on the Ak ' and A# polypeptides are not located at the polymorphic residues at positions 40, 63, and 65-67 . The amino acid substitutions at these positions could change the conformation of the binding sites located in different parts of the Ak or Ad molecule by allosteric effects. However, we do not favor this interpretation . The regions around the residues at positions 40, 63, and 65-67 contain multiple charged residues and are predicted (data not shown) to be markedly hydrophilic according to a previously described algorithm (43) . Consequently, these regions are expected to be exposed on the surface of the molecule . In addition, single or multiple substitutions of amino acids at other polymorphic positions in the (3, domain of the Ap polypeptide do not measurably alter antibody binding sites. Preliminary results indicate that substitutions of Ad characteristic residues in either the NH 2-or COOH-terminal part of the Ak 0, domain impair the ability of the mutant Aa polypeptide to be expressed with either the Aa or Ad 3 polypeptide (our unpublished results) . Thus, the polymorphic residues in the NH 2-and COOH-terminal part of the A,e chain may be located near polymorphic residues of the Aa chain and may not be sufficiently exposed at the surface of the molecule to provoke a strong antibody response . A similar hypothesis was formulated by Braunstein and Germain (38) from analyses of L cells expressing A# polypeptides encoded by half-exon-shuffled genes. Their results suggested that the polymorphic residues in the NH 2-terminal half of the ,Q, domain determines the allele-specific a/a chain pairing, whereas the polymorphic residues in the 000H-terminal half of the a, domain determine the antigenic determinants recognized by most A#-reactive antibodies . The analysis of allospecific antibody binding sites presented here is limited to those residues that differ between the As and As polypeptide. It has previously been shown that other residues in addition to the polymorphic residues that we have identified influence the binding of certain Ak s-reactive mAbs . For example, sequence analysis of genes encoding five different mutant As polypeptides, selected with A' reactive mAbs for altered antibody binding properties, revealed that substitutions of nonpolymorphic residues adjacent to the polymorphic region around positions 63 and 65-67 can also affect the conformation of the binding sites recognized by these Ak k-reactive antibodies (21, 42) . Moreover, polymorphic residues other than those located at positions 40, 63, and 65-67 may influence the binding of some of the tested mAbs . For example, mAbs 39B, 39E, 40M, and 40F, whose binding to the Ak k polypeptide is lost after substitution of the residues at positions 63 or 65-67, do not bind to the As polypeptide, although this allele shares amino acids from position 62-69 and at position 40 with the Ak # polypeptide (8, 33) . This example demonstrates that in comparisons of alleles exhibiting multiple amino acid differences it is difficult to identify which amino acids determine antibody binding sites solely on the basis of crossreactivity patterns and sequence data .
The physiologic significance of la antigens stems from their role as restriction elements for helper T cells. Recent studies indicate that T cell recognition of la molecules is influenced by polymorphic residues on both a and ,B polypeptides (10) and by residues in different regions of the a, domain (24, 44) . In contrast, most allospecific antibody binding sites on la molecules are determined by either the a or (3 polypeptides, and as we have shown here, only a limited number of 0, polymorphic residues are involved in determining these sites. However, the results of the assays used to identify T cell recognition sites are affected by at least two potentially different regions on the la molecule, regions that bind la antigen and regions that bind the T cell receptor. Analysis of this panel of mutant Ak-expressing cell lines with Ak-or A d-restricted T lymphocytes that exhibit specificity for defined peptide antigens together with binding analyses with labeled peptides to isolated mutant Ak molecules should facilitate the characterization of the complex molecular interactions that occur between la, processed antigen, and the TCR.
Summary
To identify which polymorphic residues determine the allospecific antibody binding sites on As polypeptides, mutant A' genes were constructed encoding single or multiple amino acids of the d allele at 14 polymorphic positions in the ,Q, domain. Cell lines expressing these genes were analyzed by quantitative immunofluorescence using 16 mAbs reactive to Ak k or As. Substitution of d allele residues at positions 63 and 65-67 in the A' polypeptide resulted in the loss of binding of all Ak-reactive antibodies and the gain of binding of most As-reactive antibodies . Two As-reactive mAbs bound to the mutant As s polypeptide containing d allele-characteristic residue at position 40. In contrast, substitution of the other polymorphic residues in the NH2-terminal and COOH-terminal regions of the ,Q, domain did not alter antibody binding .
